US pharmaceutical giant Pfizer said Wednesday it was abandoning plans for a $160 billion merger With Allergan, citing new US rules cracking down on tie ups aimed at saving on taxes.

The deal with the Irish-based firm would have created the world's largest pharmaceutical company.

Pfizer said in a statement the two companies had agreed jointly to scrap the project.